tumor necrosis factors

Expert consensus recommendations for the diagnosis and treatment of chronic non-bacterial osteitis (CNO) in adults
Elizabeth M Winter, Olaf M Dekkers, Caroline M Andreasen, Salvatore D’Angelo, Natasha M Appelman-Dijkstra, Simone Appenzeller, Gunter Assmann, Judith S Bubbear, Oana O Bulaicon, Roland Chapurlat, Varvara Choida, Gavin Peter Ross Clunie, Dimitrios Daoussis, Torsten Diekhoff, Marcel Flendrie, Olivier Fogel, Roba Ghossan, Hermann Girschick, Femke van Haalen, Neveen A T Hamdy, Barbara Hauser, Christian M Hedrich, Philip S Helliwell, Kay Geert Hermann, Antonella Insalaco, Anne Grethe Jurik, Mitsumasa Kishimoto, Willem Lems, Paivi Miettunen, Burkhard Muche, Ana Navas Cañete, Natalia Palmou-Fontana, Frits Smit, James Teh, Charlotte Verroken, Kurt de Vlam, Daniel Wendling, Wei Zhou, Hans-Georg Zmierczak, Anne T Leerling

Annals of the Rheumatic Diseases Nov 2024, ard-2024-226446; DOI: 10.1136/ard-2024-226446
Proinflammatory phenotype of B10 and B10pro cells elicited by TNF-α in rheumatoid arthritis
Fanlei Hu, Lianjie Shi, Xiaohang Liu, Yingjia Chen, Xia Zhang, Yuan Jia, Xu Liu, Jianping Guo, Huaqun Zhu, Hongjiang Liu, Liling Xu, Yingni Li, Ping Wang, Xiangyu Fang, Jimeng Xue, Yang Xie, Chaonan Wei, Jing Song, Xi Zheng, Yan-Ying Liu, Yuhui Li, Limin Ren, Dakang Xu, Liwei Lu, Xiaoyan Qiu, Rong Mu, Jing He, Min Wang, Xuan Zhang, Wanli Liu, Zhanguo Li

Annals of the Rheumatic Diseases May 2024, 83 (5) 576-588; DOI: 10.1136/ard-2023-224878
Greetings from the editor 2024
Josef S Smolen

Annals of the Rheumatic Diseases Jan 2024, 83 (1) 1-3; DOI: 10.1136/ard-2023-225240
Correspondence on "ASAS-EULAR recommendations for the management of axial spondyloarthritis: 2022 update"
Juergen Braun

Annals of the Rheumatic Diseases Sep 2023, 82 (9) e205; DOI: 10.1136/ard-2023-223935
Severity of COVID-19 and survival in patients with rheumatic and inflammatory diseases: data from the French RMD COVID-19 cohort of 694 patients
FAI2R /SFR/SNFMI/SOFREMIP/CRI/IMIDIATE consortium and contributors

Annals of the Rheumatic Diseases Apr 2021, 80 (4) 527-538; DOI: 10.1136/annrheumdis-2020-218310
Prevalence, admission rates and hypoxia due to COVID-19 in patients with rheumatic disorders treated with targeted synthetic or biologic disease modifying antirheumatic drugs or methotrexate: a nationwide study from Iceland
Aron Hjalti Bjornsson, Gerdur Grondal, Mar Kristjansson, Thorunn Jonsdottir, Thorvardur Jon Love, Bjorn Gudbjornsson

Annals of the Rheumatic Diseases May 2021, 80 (5) 671-672; DOI: 10.1136/annrheumdis-2020-219564
Cardiovascular effects of biological versus conventional synthetic disease-modifying antirheumatic drug therapy in treatment-naïve, early rheumatoid arthritis
Sven Plein, Bara Erhayiem, Graham Fent, Sarah Horton, Raluca Bianca Dumitru, Jacqueline Andrews, John P Greenwood, Paul Emery, Elizabeth MA Hensor, Paul Baxter, Sue Pavitt, Maya H Buch

Annals of the Rheumatic Diseases Nov 2020, 79 (11) 1414-1422; DOI: 10.1136/annrheumdis-2020-217653
Contrasting contributions of TNF from distinct cellular sources in arthritis
Andrey Kruglov, Marina Drutskaya, Dirk Schlienz, Ekaterina Gorshkova, Katharina Kurz, Lars Morawietz, Sergei Nedospasov

Annals of the Rheumatic Diseases Nov 2020, 79 (11) 1453-1459; DOI: 10.1136/annrheumdis-2019-216068

Log in using your username and password

Main menu

Log in using your username and password

You are here

tumor necrosis factors